Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,413Revenue $M1,117Net Margin (%)15.6Z-Score5.2
Enterprise Value $M3,941EPS $3.3Operating Margin %26.2F-Score6
P/E(ttm))20.3Cash Flow Per Share $4.9Pre-tax Margin (%)25.0Higher ROA y-yN
Price/Book3.510-y EBITDA Growth Rate %0Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %68.1Current Ratio1.5Lower Leverage y-yY
Price/Cash Flow10.6y-y EBITDA Growth Rate %-8.3ROA % (ttm)8.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)13.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.2ROI % (ttm)20.2Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRJoel Greenblatt 2014-03-31 Add0.17%$90.67 - $113.39
($102.75)
$ 91.59-11%Add 62.64%316,489
UTHRJohn Hussman 2013-12-31 Reduce-1%$80.03 - $114.51
($89.93)
$ 91.592%Reduce -62.57%134,000
UTHRJoel Greenblatt 2013-12-31 Reduce-0.45%$80.03 - $114.51
($89.93)
$ 91.592%Reduce -47.71%194,595
UTHRJohn Hussman 2013-09-30 Reduce-0.33%$66.1 - $79.58
($73.08)
$ 91.5925%Reduce -23.5%358,000
UTHRVanguard Health Care Fund 2013-09-30 Sold Out -0.32%$66.1 - $79.58
($73.08)
$ 91.5925%Sold Out0
UTHRDavid Dreman 2013-09-30 Sold Out -0.12%$66.1 - $79.58
($73.08)
$ 91.5925%Sold Out0
UTHRJoel Greenblatt 2013-06-30 Add0.13%$59.64 - $69.31
($64.42)
$ 91.5942%Add 15.34%341,330
UTHRDavid Dreman 2012-12-31 Buy 0.09%$44.99 - $58.91
($52.11)
$ 91.5976%New holding, 57025 sh.57,025
UTHRJohn Hussman 2012-09-30 Buy 0.67%$49.73 - $58.2
($54.16)
$ 91.5969%New holding, 500000 sh.500,000
UTHRJoel Greenblatt 2012-06-30 Add0.6%$41.19 - $49.51
($44.12)
$ 91.59108%Add 101.59%332,744
UTHRRichard Perry 2012-06-30 Sold Out -0.04%$41.19 - $49.51
($44.12)
$ 91.59108%Sold Out0
UTHRJoel Greenblatt 2012-03-31 Add0.31%$45.54 - $50.99
($45.17)
$ 91.59103%Add 82.68%165,063
UTHRRichard Perry 2012-03-31 Buy 0.04%$45.54 - $50.99
($45.17)
$ 91.59103%New holding, 15300 sh.15,300
UTHRJoel Greenblatt 2011-12-31 Add0.15%$37.21 - $47.54
($41.57)
$ 91.59120%Add 38.75%90,355
UTHRJoel Greenblatt 2011-09-30 Add0.29%$37.47 - $57.38
($48.47)
$ 91.5989%Add 274.82%65,122
UTHRVanguard Health Care Fund 2011-09-30 Add0.16%$37.47 - $57.38
($48.47)
$ 91.5989%Add 77.9%1,787,000
UTHRMichael Price 2011-09-30 Sold Out -0.1%$37.47 - $57.38
($48.47)
$ 91.5989%Sold Out0
UTHRGeorge Soros 2011-09-30 Sold Out -0.0776%$37.47 - $57.38
($48.47)
$ 91.5989%Sold Out0
UTHRVanguard Health Care Fund 2011-06-30 Add0.18%$53.49 - $70.7
($63.39)
$ 91.5944%Add 183.36%1,004,500
UTHRJoel Greenblatt 2011-06-30 Buy 0.13%$53.49 - $70.7
($63.39)
$ 91.5944%New holding, 17374 sh.17,374
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
UTHR Joel Greenblatt 2014-03-31316,4890.660.45+62.64%
UTHR John Hussman 2014-03-31134,0000.280.94
Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE ACEO 2014-07-17Sell3,833$90.870.79view
Ferrari John MaximCFO 2014-07-17Sell10,000$89.742.06view
JEFFS ROGERPresident & COO 2014-07-11Sell10,000$93.06-1.58view
ROTHBLATT MARTINE ACEO 2014-07-10Sell9,187$92.33-0.8view
ROTHBLATT MARTINE ACEO 2014-07-03Sell3,833$91.370.24view
DWEK RAYMONDDirector 2014-07-03Sell3,000$91.420.19view
CAUSEY CHRISTOPHERDirector 2014-07-03Sell1,500$91.62-0.03view
Ferrari John MaximCFO 2014-07-03Sell10,000$90.581.12view
ROTHBLATT MARTINE ACEO 2014-06-26Sell3,833$87.235view
JEFFS ROGERPresident & COO 2014-06-20Sell10,000$875.28view

Press Releases about UTHR :

    Quarterly/Annual Reports about UTHR:

    News about UTHR:

    Articles On GuruFocus.com
    Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
    High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares Dec 27 2013 
    John Hussman's Third Quarter Top 5 Nov 07 2013 
    Vanguard Health Care Fund Selling Update Oct 30 2013 
    comment on UTHR May 11 2013 
    Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns May 09 2013 
    5 Fast-Growing Small-Cap Stocks to Watch Mar 26 2013 
    comment on UTHR Mar 23 2013 
    fd Jan 12 2013 
    bmn Jan 12 2013 

    More From Other Websites
    United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open... Jul 22 2014
    United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open... Jul 22 2014
    Supernus Up on Non-Dilutive Royalty Deal Jul 10 2014
    Pluristem Initiates Trial in South Korea Jul 09 2014
    Supernus to Receive $30 Million in Non-Dilutive Royalty Deal Jul 08 2014
    United Therapeutics draws bulls Jul 08 2014
    UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments... Jun 27 2014
    United Therapeutics Announces Additional $500 Million Share Repurchase Program Jun 27 2014
    United Therapeutics (UTHR) Marked As A Dead Cat Bounce Stock Jun 16 2014
    Weakness Seen in United Therapeutics (UTHR): Stock Tumbles 8.0% Jun 16 2014
    SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into United... Jun 09 2014
    [video] Momentum trades alive: ARCB, UTHR May 21 2014
    Supernus Receives $2 Million Milestone for United Therapeutics' Launch of Orenitram(TM) May 20 2014
    Industry Ranks May 2014 May 11 2014
    Insider Trading Alert - K, EQR And UTHR Traded By Insiders May 08 2014
    Synthetic Genomics Inc. Signs Collaborative Research and Development Agreement with Lung... May 06 2014
    Genome scientist Craig Venter in deal to make humanized pig organs May 06 2014
    UNITED THERAPEUTICS CORP Financials May 03 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide